Nimesulide 50mg Tablet Franchise in Ahmedabad

Mild Pain & Fever Relief Tablet Supplier in Mumbai

Nimoplit 50 Tablet Distributor in Delhi

NSAID Pain Relief Tablet Franchise Opportunity in Bangalore

Acute Pain Management Tablet Stockist in Hyderabad
Nimesulide 50mg Export & Manufacturing in Chandigarh

Home/Products /nimesulide-50mg-tablet

Nimoplit 50 Tablet

Composition : Nimesulide (50mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Nimoplit 50 Tablet contains Nimesulide 50mg, an effective NSAID formulated for the management of mild to moderate pain, inflammation, and fever. It is commonly used in early-stage musculoskeletal pain, dental discomfort, and acute inflammatory conditions requiring gentle yet effective relief.

Nimesulide acts by inhibiting prostaglandin synthesis, helping reduce inflammation and pain while improving patient comfort. The lower strength makes it suitable where controlled analgesic therapy is required with good tolerability.

For distributors and healthcare suppliers, Nimoplit 50 Tablet is a frequently prescribed general medicine, widely used by physicians for short-term pain and fever management. Its everyday applicability ensures regular movement across retail and clinical channels.

Adding Nimoplit 50 Tablet to your pain management and general medicine segment creates strong opportunities in pharmacies, clinics, hospitals, export markets, and third-party manufacturing. Its dependable efficacy, flexible dosing strength, and broad prescriber acceptance make it a valuable product in pharmaceutical distribution portfolios.

Read More

About the Product

Nimoplit 50 Tablet contains Nimesulide 50mg, an effective NSAID formulated for the management of mild to moderate pain, inflammation, and fever. It is commonly used in early-stage musculoskeletal pain, dental discomfort, and acute inflammatory conditions requiring gentle yet effective relief.

Nimesulide acts by inhibiting prostaglandin synthesis, helping reduce inflammation and pain while improving patient comfort. The lower strength makes it suitable where controlled analgesic therapy is required with good tolerability.

For distributors and healthcare suppliers, Nimoplit 50 Tablet is a frequently prescribed general medicine, widely used by physicians for short-term pain and fever management. Its everyday applicability ensures regular movement across retail and clinical channels.

Adding Nimoplit 50 Tablet to your pain management and general medicine segment creates strong opportunities in pharmacies, clinics, hospitals, export markets, and third-party manufacturing. Its dependable efficacy, flexible dosing strength, and broad prescriber acceptance make it a valuable product in pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, abdominal discomfort, heartburn, or diarrhea. Rare but serious side effects include liver toxicity, gastrointestinal bleeding, or allergic reactions. Patients should seek medical advice if severe or persistent symptoms occur.

Nimoplit 50 Tablet is indicated for the management of mild to moderate pain, inflammatory conditions, musculoskeletal pain, dental pain, and fever, as prescribed by a healthcare professional.

Nimoplit 50 Tablet should be used strictly as prescribed and is recommended for short-term use only. Patients with liver disease, gastrointestinal ulcers, bleeding disorders, or hypersensitivity to NSAIDs should inform their doctor before use. Avoid alcohol consumption during treatment.

Store Nimoplit 50 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack is intact. Do not use the tablet beyond its expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation